Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 3
1965 1
1966 3
1967 3
1968 3
1969 4
1971 6
1972 5
1973 10
1974 6
1975 102
1976 122
1977 99
1978 119
1979 132
1980 143
1981 175
1982 176
1983 240
1984 326
1985 299
1986 368
1987 578
1988 775
1989 1187
1990 1270
1991 1377
1992 1408
1993 1581
1994 1652
1995 1637
1996 1901
1997 1985
1998 2274
1999 2297
2000 2986
2001 2697
2002 3015
2003 3227
2004 3646
2005 3744
2006 3927
2007 4296
2008 4324
2009 4358
2010 4722
2011 5486
2012 6187
2013 6716
2014 7151
2015 7220
2016 7511
2017 7536
2018 7395
2019 7469
2020 8683
2021 9768
2022 9593
2023 8963
2024 8257
2025 4345

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157,054 results

Results by year

Filters applied: Abstract, Review. Clear all
Quoted phrase not found in phrase index: "coeliacoduodenal part"
Page 1
Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.
Hane FT, Robinson M, Lee BY, Bai O, Leonenko Z, Albert MS. Hane FT, et al. J Alzheimers Dis. 2017;57(3):645-665. doi: 10.3233/JAD-160907. J Alzheimers Dis. 2017. PMID: 28269772 Free PMC article. Review.
Part 1 of this review covers pathogenesis, both on a molecular and macro scale. Part 2 review genetics and epidemiology, and part 3 covers diagnosis and treatment. This part of the review, diagnosis and treatment, reviews the latest diagnostic criteria
Part 1 of this review covers pathogenesis, both on a molecular and macro scale. Part 2 review genetics and epidemiology, and
Oxygen Therapy Part 1 - History, Physiology, and Evaluation.
Wemple ML, Swenson KE, Swenson ER. Wemple ML, et al. NEJM Evid. 2023 May;2(5):EVIDra2300005. doi: 10.1056/EVIDra2300005. Epub 2023 Apr 25. NEJM Evid. 2023. PMID: 38320050 Review.
History, Physiology, and Evaluation of Oxygen TherapyOxygen is standard therapy for acute cardiopulmonary diseases, and long-term oxygen therapy is common in the outpatient setting. In part I of a two-part review, Wemple and colleagues discuss the physiology of tiss …
History, Physiology, and Evaluation of Oxygen TherapyOxygen is standard therapy for acute cardiopulmonary diseases, and long-term oxygen the …
Local and regional anaesthesia in dogs and cats: Descriptions of specific local and regional techniques (Part 2).
Grubb T, Lobprise H. Grubb T, et al. Vet Med Sci. 2020 May;6(2):218-234. doi: 10.1002/vms3.218. Epub 2020 Jan 21. Vet Med Sci. 2020. PMID: 31965749 Free PMC article. Review.
For efficacy and safety, this class of drugs is recommended as part of the analgesic protocol in the majority of surgical procedures and traumatic injuries. ...In Part 1 of this topic, detailed information on local anaesthetic drugs commonly used in small animal pra …
For efficacy and safety, this class of drugs is recommended as part of the analgesic protocol in the majority of surgical procedures …
A systematic review assessing soft tissue augmentation techniques.
Thoma DS, Benić GI, Zwahlen M, Hämmerle CH, Jung RE. Thoma DS, et al. Clin Oral Implants Res. 2009 Sep;20 Suppl 4:146-65. doi: 10.1111/j.1600-0501.2009.01784.x. Clin Oral Implants Res. 2009. PMID: 19663961 Free article.
The focused question was: is one method superior over others for augmentation and stability of the augmented soft tissue in terms of increasing the width of keratinized tissue (part 1) and gain in soft tissue volume (part 2). METHODS: A Medline search was performed …
The focused question was: is one method superior over others for augmentation and stability of the augmented soft tissue in terms of increas …
Understanding and improving multidisciplinary team working in geriatric medicine.
Ellis G, Sevdalis N. Ellis G, et al. Age Ageing. 2019 Jul 1;48(4):498-505. doi: 10.1093/ageing/afz021. Age Ageing. 2019. PMID: 30855656 Review.
This paper is a reflective review, grounded on our respective expertise in geriatric medicine and improvement science, on practice and its changing patterns within geriatric medicine, and the role of MDTs within it (Part 1). It offers a perspective from behavioural safety …
This paper is a reflective review, grounded on our respective expertise in geriatric medicine and improvement science, on practice and its c …
Vulvar Neoplasms (Part II).
Sanchez I, Raffi J, Kraus CN. Sanchez I, et al. Urology. 2022 Jul;165:31-35. doi: 10.1016/j.urology.2022.02.007. Epub 2022 Feb 23. Urology. 2022. PMID: 35218865 Free article. Review.
Herein, we provide an overview of noninfectious inflammatory vulvar dermatoses (Part I) and benign and malignant vulvar neoplasms (Part II), grouped by morphologic findings. ...
Herein, we provide an overview of noninfectious inflammatory vulvar dermatoses (Part I) and benign and malignant vulvar neoplasms ( …
Inflammatory Vulvar Dermatoses (Part I).
Sanchez I, Raffi J, Kraus CN. Sanchez I, et al. Urology. 2022 Jul;165:23-30. doi: 10.1016/j.urology.2022.03.025. Epub 2022 Apr 10. Urology. 2022. PMID: 35413374 Free article. Review.
Herein, we provide an overview of noninfectious inflammatory vulvar dermatoses (part I) and benign and malignant vulvar neoplasms (part II), grouped by morphologic findings. ...
Herein, we provide an overview of noninfectious inflammatory vulvar dermatoses (part I) and benign and malignant vulvar neoplasms ( …
Representation of autism in fictional media: A systematic review of media content and its impact on viewer knowledge and understanding of autism.
Jones SC, Gordon CS, Mizzi S. Jones SC, et al. Autism. 2023 Nov;27(8):2205-2217. doi: 10.1177/13623613231155770. Epub 2023 Feb 19. Autism. 2023. PMID: 36802826 Free PMC article.
This work aimed to review previous research to understand how autistic people have been represented in fictional media (Part A). It also sought to understand whether viewing fictional portrayals of autism has an impact on people's knowledge of autism and attitudes towards …
This work aimed to review previous research to understand how autistic people have been represented in fictional media (Part A). It a …
Alveolar Soft Part Sarcoma.
Jaber OI, Kirby PA. Jaber OI, et al. Arch Pathol Lab Med. 2015 Nov;139(11):1459-62. doi: 10.5858/arpa.2014-0385-RS. Arch Pathol Lab Med. 2015. PMID: 26516944 Free article. Review.
Alveolar soft part sarcoma is a rare neoplasm usually arising in the soft tissues of the lower limbs in adults and in the head and neck region in children. ...It is characterized by a specific chromosomal alteration, der(17)t(X:17)(p11:q25), resulting in fusion of the tran …
Alveolar soft part sarcoma is a rare neoplasm usually arising in the soft tissues of the lower limbs in adults and in the head and ne …
Medicare Part B Drugs: Trends in Spending and Utilization, 2008-2021: Issue Brief.
Nguyen NX, Olsen TA, Sheingold SH, De Lew N. Nguyen NX, et al. Washington (DC): Office of the Assistant Secretary for Planning and Evaluation (ASPE); 2023 Jun 9. Report No.: HP-2023-17. Washington (DC): Office of the Assistant Secretary for Planning and Evaluation (ASPE); 2023 Jun 9. Report No.: HP-2023-17. PMID: 39146449 Free Books & Documents. Review.
The report showed that Medicare Part B drugs had the fastest rate of spending growth among drugs in the Medicare program over the past few decades. Part B drug spending per enrollee in traditional Medicare (known as fee-for-service or FFS) grew on average at 9.2 per …
The report showed that Medicare Part B drugs had the fastest rate of spending growth among drugs in the Medicare program over the pas …
157,054 results
You have reached the last available page of results. Please see the User Guide for more information.